Directory

Every key opinion leader in the directory, every fact cited to its public source.

Clear all

Showing 1–8 of 8 KOLs

Sort

Drug: Xofigo

Nicholas Vogelzang, MD

Comprehensive Cancer Centers of Nevada

Active 2023

Enriched profilefindmyKOL typeGenitourinaryHematology / OncologyWest · NV

1,129
publications: 115
h-index: 2
trials

View profile →

Neal Shore, MD

Carolina Urologic Research Center

Active 2026

Enriched profileGenitourinaryUrologySoutheast · SC

1,294
publications: 85
h-index: 19
trials

View profile →

Emmanuel Antonarakis, MD

University of Minnesota Medical School

Active 2026

Enriched profilefindmyKOL typeGenitourinaryMedical OncologyMidwest · MN

1,495
publications: 83
h-index: 8
trials

View profile →

Charles Ryan, MD

Memorial Sloan Kettering Cancer Center

Active 2026

Enriched profilefindmyKOL typeGenitourinaryMedical OncologyMidwest · MN

794
publications: 71
h-index: 9
trials

View profile →

Guru Sonpavde, MD

AdventHealth Cancer Institute

Active 2026

Enriched profilefindmyKOL typeGenitourinaryMedical OncologySoutheast · FL

1,124
publications: 77
h-index: 17
trials

View profile →

Daniel Spratt, MD

University Hospitals Seidman Cancer Center

Active 2026

Enriched profilefindmyKOL typeGenitourinaryRadiation OncologyMidwest · OH

976
publications: 76
h-index: 8
trials

View profile →

Elisabeth Heath, MD

Mayo Clinic

Active 2025

Enriched profilefindmyKOL typeGenitourinaryMedical OncologyMidwest · MN

1,254
publications: 60
h-index: 13
trials

View profile →

Matthew Rettig, MD

University of California, Los Angeles

Active 2026

Enriched profileGenitourinaryHematology / OncologyWest

559
publications: 61
h-index: 12
trials

View profile →